Vaxart Inc Revenue per Employee (VXRT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Vaxart Inc   (VXRT)
 

Vaxart Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Vaxart Inc 's Revenue per employee fell on a trailing twelve month basis to $ 3,739,446, below the company average number of $524,615.
Within the Healthcare sector Employees of 10 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 233, from total ranking in previous quarter at 319. Vaxart Inc has 65 employees.


What is Sales per Employee Ratio?







VXRT Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -31.58 % 87.9 % 586.46 % 1367.93 % 520.68 %
Sales per Employee (TTM) $ 3,739,446 3,932,446 3,650,123 2,280,062 1,241,908
VXRT's Total Ranking # 233 # 319 # 390 # 713 # 1158
Seq. Revenue Change -30.7 % -62.37 % 43.95 % 82.26 % 90.31 %


Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 1
Healthcare Sector # 11
Overall Market # 233

Revenue per Employee Statistics
High Average Low
$ 3,932,446 $ 524,615 $ 7,246
(Mar 31 2026)   (Mar 31 2022)



Financial Statements
Vaxart Inc 's Revenue MRQ $ 27 Millions Visit VXRT's Income Statement
Vaxart Inc 's Revenues TTM $ 243 Millions Visit VXRT's aggregate revenue growth
What are VXRT's Sales? Visit VXRT's Sales by Segment




Other Ratios
Vaxart Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VXRT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VXRT's Competitors
Revenue per Employee for VXRT's Suppliers
Revenue per Employee for VXRT's Customers

You may also want to know
VXRT's Sales Growth Rates VXRT's Pe Price to earnings ratio VXRT's Receivables Turnover Ratio VXRT's Stock Quote
VXRT's Net Income Growth Rates VXRT's Ps Price to Sales ratio VXRT's Sales per Employee VXRT's Asset Turnover Ratio
VXRT's Net Margin VXRT's Pb Price to Book ratio VXRT's Financial Strength Ratios VXRT's Dividend Payout Ratio
Date modified: 2026-09-01T20:16:20+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.